Investtech.com

Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Validea Market Legends ETF VALX Apr 28, 2017 0.27 0.00   
 Valley Financial Corp VYFC Apr 28, 2017 21.36 0.00   
 Valley National Bancorp VLYWW Apr 28, 2017 0.03 0.00   
 Value Line VALU Apr 28, 2017 17.48 +0.46   
 Valueclick Inc VCLK Apr 28, 2017 21.00 0.00   
 Valuevision Media VVTV Apr 28, 2017 6.08 0.00   
 Vanda Pharmaceuticals Inc VNDA Apr 28, 2017 15.25 +0.33   
 VanEck Vectors Biotech ETF BBH Apr 28, 2017 121.99 +0.62   
 VanEck Vectors Generic Drugs ETF GNRX Apr 28, 2017 22.67 +0.56   
 VanEck Vectors Pharmaceutical ETF PPH Apr 28, 2017 55.20 -0.27   
 Vanguard Emerging Markets Gover VWOB Apr 28, 2017 80.43 +0.25   
 Vanguard International Dividend Appreciation ETF VIGI Apr 28, 2017 59.31 -0.24   
 Vanguard International High Dividend Yield ETF VYMI Apr 28, 2017 61.45 +0.07   
 Vanguard Natural Resources LLC VNRBP Apr 28, 2017 2.00 0.00   
 Vanguard Natural Resources LLC VNRCP Apr 28, 2017 2.00 0.00   
 Vanguard Natural Resources Llc VNR Apr 28, 2017 0.20 0.00   
 Vanguard Natural Resources Llc Pfd. Series A VNRAP Apr 28, 2017 2.26 0.00   
 Vanguard Short-Term Inflation-P VTIP Apr 28, 2017 49.46 +0.04   
 Vanguard Total International Bo BNDX Apr 28, 2017 54.35 -0.09   
 Varonis Systems, Inc. VRNS Apr 28, 2017 31.40 +0.48   
 Vasco Data Security International VDSI Apr 28, 2017 13.50 -0.74   
 Vascular Biogenics Ltd. VBLT Apr 28, 2017 5.70 -1.72   
 Vascular Solutions VASC Apr 28, 2017 56.00 0.00   
 VBI Vaccines, Inc. VBIV Apr 28, 2017 4.49 +0.22   
 Vca Antech WOOF Apr 28, 2017 91.57 -0.09   
 Vcg Holding Corp. VCGH Apr 28, 2017 2.24 0.00   
 Veeco Instruments Inc VECO Apr 28, 2017 33.00 -3.51   
 Velocityshares Emerging Asia Dr ASDR Apr 28, 2017 68.90 0.00   
 Velocityshares Emerging Markets EMDR Apr 28, 2017 49.28 0.00   
 Velocityshares Equal Risk Weigh ERW Apr 28, 2017 49.00 0.00   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here www.investtech.com/disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK